Paid-in Capital Increase Decision Amended
에이프릴바이오
397030
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2604
Risk-adjusted indicator based on 2604 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Event Type: Paid-in Capital Increase
AI Analysis Summary
AprilBio Co.,Ltd. has announced an amendment to its decision on a paid-in capital increase. While specific figures are not available, a capital increase typically leads to share dilution, potentially negatively impacting existing shareholder value. The financial impact will depend on the size of the issuance and the intended use of funds.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.